Trademark: 88368343
Word
INKAR
Status
Pending
Status Code
734
Status Date
Wednesday, February 7, 2024
Serial Number
88368343
Mark Type
5000
Filing Date
Tuesday, April 2, 2019
Published for Opposition
Tuesday, June 1, 2021

Trademark Owner History
Fate Therapeutics, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for the treatment of cancer; therapeutic agents for the treatment of cancer; cells and cell-derived preparations for medical, clinical, and therapeutic use; cells and cell-derived preparations for clinical, medicinal, and therapeutic purposes; biological preparations for therapeutic purposes; biological preparations for a therapeutic material, namely, cell lines used for medical cell therapy; pharmaceutical preparations and substances for the treatment of immunological diseases and cancer
1 cells and cell-derived preparations for scientific, laboratory, and therapeutic research
44 providing information relating to medicinal and therapeutic properties of cells and cell-derived preparations
42 research in the fields of cancer, and immunological and inflammatory diseases; product development in the fields of science, medicine, pharmaceuticals, therapeutics and research related thereto; providing information relating to clinical research properties of cells and cell-derived preparations
The mark consists of the letters "iNKAR", where the letters "NKAR" appear in upper-case form and the letter "I" appears in lower-case form.
Color is not claimed as a feature of the mark.

Trademark Events
Feb 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2024
Sou Extension 5 Granted
Jan 25, 2024
Sou Extension 5 Filed
Feb 7, 2024
Case Assigned To Intent To Use Paralegal
Jan 25, 2024
Sou Teas Extension Received
Jul 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 6, 2023
Sou Extension 4 Granted
Jul 6, 2023
Sou Extension 4 Filed
Jul 6, 2023
Sou Teas Extension Received
Dec 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2022
Sou Extension 3 Granted
Dec 20, 2022
Sou Extension 3 Filed
Dec 20, 2022
Sou Teas Extension Received
Jun 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2022
Sou Extension 2 Granted
Jun 7, 2022
Sou Extension 2 Filed
Jun 7, 2022
Sou Teas Extension Received
Jan 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 21, 2022
Sou Extension 1 Granted
Jan 21, 2022
Sou Extension 1 Filed
Jan 21, 2022
Sou Teas Extension Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 29, 2021
Law Office Publication Review Completed
Apr 23, 2021
Assigned To Lie
Apr 22, 2021
Approved For Pub - Principal Register
Apr 20, 2021
Examiner's Amendment Entered
Apr 20, 2021
Notification Of Examiners Amendment E-Mailed
Apr 20, 2021
Examiners Amendment E-Mailed
Apr 20, 2021
Examiners Amendment -Written
Apr 14, 2021
Previous Allowance Count Withdrawn
Mar 30, 2021
Withdrawn From Pub - Og Review Query
Mar 16, 2021
Approved For Pub - Principal Register
Feb 20, 2021
Teas/Email Correspondence Entered
Feb 19, 2021
Correspondence Received In Law Office
Feb 19, 2021
Teas Response To Office Action Received
Aug 19, 2020
Notification Of Non-Final Action E-Mailed
Aug 19, 2020
Non-Final Action E-Mailed
Aug 19, 2020
Non-Final Action Written
Jul 29, 2020
Suspension Checked - To Attorney For Action
Jul 28, 2020
Assigned To Lie
Dec 28, 2019
Notification Of Letter Of Suspension E-Mailed
Dec 28, 2019
Letter Of Suspension E-Mailed
Dec 28, 2019
Suspension Letter Written
Dec 13, 2019
Teas/Email Correspondence Entered
Dec 12, 2019
Correspondence Received In Law Office
Dec 12, 2019
Teas Response To Office Action Received
Jun 19, 2019
Notification Of Non-Final Action E-Mailed
Jun 19, 2019
Non-Final Action E-Mailed
Jun 19, 2019
Non-Final Action Written
Jun 12, 2019
Assigned To Examiner
Apr 20, 2019
New Application Office Supplied Data Entered
Apr 5, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24